79
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin

, , , , , & show all
Pages 1027-1034 | Published online: 17 May 2011

References

  • ChenHBiWCaoBA novel podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-glycoprotein in multidrug resistance cell line KBV200Eur J Pharmacol2010627697419879873
  • MiettinenaSGrenmandSYlikomiaTInhibition of P-glycoprotein-mediated docetaxel efflux sensitizes ovarian cancer cells to concomitant docetaxel and SN-38 exposureAnticancer Drugs2009206776
  • AlexiouCSchmidRJJurgonsRTargeting cancer cells: magnetic nanoparticles as drug carriersEur Biophys J20063544645016447039
  • NobsLBucheggerFCurnyRCurrent methods for attaching targeting ligands to liposomes and nanoparticlesJ Pharm Sci2004931980199215236448
  • AllenTMLigand-targeted therapeutics in anticancer therapyNat Rev Cancer2002275076312360278
  • DiasAMHussainAMarcosASA biotechnological perspective on the application of iron oxide magnetic colloids modified with polysaccharidesBiotechnol Adv2011914215520959138
  • ChengJWuWWChenBAEffect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cellsInt J Nanomedicine2009420921619918367
  • ChenBAChengJShenMFMagnetic nanoparticles of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cellsInt J Nanomedicine20094657119421371
  • WangJChenBAChengJSynthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles in vitroInt J Nanomedicine2010620321121445276
  • KohoriFSakaiKAoyagiTControl of adriamycin cytotoxic activity using thermally responsive polymeric micelles composed of poly (N- sopropylacrylamide-co-N, N- imethylacrylamide)-bpoly(D L-lactide)Colloids Surf B Biointerfaces199916195205
  • JainTKRicheyJStrandMMagnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imagingBiomaterials2008294012402118649936
  • RossDDNovel mechanisms of drug resistance in leukemiaLeukemia2000346747310720143
  • GarcíaMGAlanizLLopesECInhibition of NF-κB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell linesLeuk Res2005291425143415982733
  • ThomasHColeyHMOvercoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoproteinCancer Control20031015916512712010
  • GottesmanMMFojoTBatesSEMultidrug resistance in cancer: role of ATP-dependent transportersNat Rev Cancer20022485811902585
  • JinJWangFPWeiHReversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrineJ Lipid Res200647515816215259
  • WangJQChenBAChengJComparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent resistance to adriamycin in human leukemia cell line K562/A02Ai Zheng20082749149518479598
  • TsuruoTNaitoMTomidaAMolecular targeting therapy of cancer: drug resistance, apoptosis and survival signalCancer Sci200394152112708468
  • JohnstoneRWRuefliAALoweSWApoptosis: a link between cancer genetics and chemotherapyCell200210815316411832206
  • YangEKorsmeyerSJMolecular thanatopsis: a discourse on the BCL2 family and cell deathBlood1996883864018695785
  • Rodriguez-NietoSZhivotovskyBRole of alterations in the apoptotic machinery in sensitivity of cancer cells to treatmentCurr Pharm Des2006124411442517168751
  • CondorelliGMoriscoCStassiGIncreased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the ratCirculation1999993071307810368127
  • KoCHShenSCHsuCSMitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspase cascadeBiochem Pharmacol20056991392715748703
  • SuzukiaAItoTKawanoHSurvivin initiates ptrocaspase 3/p21complex formation as result of interaction with Cdk4 to resist Fas-mediated cell deathOncogene2000191346135310713676